← The Wire
WHWKNasdaq
Whitehawk Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1422142
Clinical-stage oncology company developing antibody drug conjugates for cancer treatments
$206M
Market cap
$4.41
Last close
+6.0%
1D
-1.1%
5D
364K
Volume
Price · last 39 sessions+6.0%
May 4L $3.80 · H $5.10Jun 29
245
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 12, 20268-KCompany UpdateMay 21, 2026SC 13D/ASC 13D/AMay 18, 2026SC 13D/ASC 13D/AMay 14, 20268-KMaterial Agreement · Equity IssuanceMay 13, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 202610-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteJun 13, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 2025424B5424B5Apr 25, 20258-K/ACompany UpdateMar 31, 202510-K10-KMar 28, 20258-KAcquisition / DispositionMar 26, 20258-KResults of Operations · Bylaw AmendmentMar 18, 20258-KMaterial Agreement · Shareholder VoteMar 4, 2025DEFA14ADEFA14AFeb 19, 2025DEFA14ADEFA14AFeb 18, 2025DEFA14ADEFA14AFeb 5, 2025DEFA14ADEFA14ADec 30, 2024DEFA14ADEFA14ADec 20, 20248-KExecutive Change · Material AgreementDec 20, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KCompany UpdateSep 30, 20248-KExecutive ChangeSep 19, 2024SC 13GSC 13GSep 3, 2024SC 13GSC 13GAug 28, 20248-KExecutive ChangeAug 22, 20248-KExit / Disposal Costs · Company UpdateAug 21, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KShareholder VoteJun 12, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024424B5424B5May 3, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KMaterial AgreementApr 4, 202410-K10-KMar 13, 20248-KResults of OperationsMar 13, 20248-KCompany UpdateDec 14, 202310-Q10-QNov 8, 20238-K/AResults of OperationsNov 8, 20238-KResults of OperationsNov 8, 20238-KExecutive Change · Reg FD DisclosureOct 2, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KShareholder VoteJun 16, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 202310-K10-KMar 29, 20238-K/AExecutive ChangeMar 28, 20238-KExecutive Change · Results of OperationsMar 28, 20238-KExecutive Change · Reg FD DisclosureMar 3, 20238-KMaterial AgreementJan 23, 20238-KBylaw AmendmentDec 7, 20228-KDelisting NoticeNov 28, 202210-Q10-QNov 9, 20228-KExecutive Change · Results of OperationsNov 9, 2022SC 13GSC 13GOct 4, 20228-KMaterial Agreement · Equity IssuanceSep 22, 202210-Q10-QAug 10, 20228-KResults of OperationsAug 10, 20228-KAgreement TerminatedJun 30, 20228-KShareholder VoteJun 17, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 12, 2022
Insider Activity
In the 90 days to Mar 2, 2026: 3 sold $32K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Lennon David JamesCHIEF EXECUTIVE OFFICER | Sell | 5,100 | $3.31 | $17K |
| Mar 2, 2026 | Giacobello Scott M.CHIEF FINANCIAL OFFICER | Sell | 2,594 | $3.31 | $9K |
| Mar 2, 2026 | Ball BryanSee remarks | Sell | 1,834 | $3.31 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance